Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/3651
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAmrutha Krishnan K-
dc.date.accessioned2026-05-05T09:09:28Z-
dc.date.available2026-05-05T09:09:28Z-
dc.date.issued2026-05-05-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/3651-
dc.descriptionVol. 63, No. 12, No. 993en_US
dc.language.isoenen_US
dc.subjectAnticancer evaluationen_US
dc.subjectToxicity analysisen_US
dc.subjectIndirect ELISAen_US
dc.subjectApoptosisen_US
dc.subjectCell cycle arresten_US
dc.subjectRT-PCRen_US
dc.titleIn vitro validation of novel drug candidate EGFR inhibitor in treatement of colorectal cacer employing 2D and 3D cell culture techniquesen_US
dc.typeOtheren_US
Appears in Collections:Vol 63, No. 12, 2025

Files in This Item:
File Description SizeFormat 
1.pdfVol. 63, No. 12, No. 993137.64 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.